What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Novartis to acquire Cadent Therapeutics in $770m deal to bolster neuropsychiatric pipeline Find out how Novartis plans to transform neuroscience with its $770M acquisition of Cadent Therapeutics and its novel CNS treatment pipeline. bypharmanewsdailyDecember 19, 2020